Sort by 'likes'
Exploring Long COVID: Symptoms, Diagnosis and Management
Mild or moderate COVID-19 lasts for up to 2 weeks for most people. However, many who recovered from the initial infection of COVID-19 and tested negative continue to experience some long-term after effects of the disease. Such patients are referred…
Next Generation Targeted Cancer Therapies – The Cellectar Story!
CureTalks launches its new series featuring biotech companies at the cutting edge of innovation and breakthrough research with the purpose of bringing their contributions to the fore and informing the patient community. This talk series will be hosted by Gary…
HIFU for Prostate Cancer Finally Gets the FDA Nod. What to expect.
After more than 10 years of clinical trials, the Food and Drug Administration on October 9 approved the first high-intensity focused ultrasound (HIFU) device for ablation of prostate tissue. HIFU has already been approved for use in prostate tissue outside…
Breakthroughs in Reproductive Health: Leading the Way for Personalized Fertility Medicine
Over the last few decades, breakthrough advancements in the field of fertility has helped many infertile couples start a family successfully. Innovations like non-invasive tests that can identify genetic abnormalities and multi-gene panel tests have brought personalized medicine to reproductive…
Racing Toward An Ebola Vaccine, But What About A Cure?
In the absence of a proven cure for EBOLA, researchers across the country are in a frenzy to get the one vaccine which can prevent the spread of this deadly disease and also provide people offering medical care to the…